Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Emerging Infectious Diseases|January 14, 2004
Flow cytometry and T-cell response monitoring after smallpox vaccinationFabrizio Poccia, Cristiana Gioia, Carla Montesano, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 29, 2008
Interferon may prevent HIV viral rebound after HAART interruption in HIV patientsFerdinando Dianzani, Gabriella Rozera, Isabella Abbate, et al.
The Journal of Antimicrobial Chemotherapy|March 21, 2014
Low-density lipoprotein and ritonavir: an interaction between antiretrovirals and lipids mediated by P-glycoproteinMassimo Tempestilli, Federica Elisei, Eleonora Cimini, et al.
Plos One|June 19, 2015
Primary and Chronic HIV Infection Differently Modulates Mucosal Vδ1 and Vδ2 T-Cells Differentiation Profile and Effector FunctionsEleonora Cimini, Chiara Agrati, Gianpiero D'Offizi, et al.
Plos One|April 17, 2015
Granulocytic myeloid derived suppressor cells expansion during active pulmonary tuberculosis is associated with high nitric oxide plasma levelSary El Daker, Alessandra Sacchi, Massimo Tempestilli, et al.
AIDS Research and Human Retroviruses|January 28, 2017
Bone Marrow CD34<sup>+</sup> Progenitor Cells from HIV-Infected Patients Show an Impaired T Cell Differentiation Potential Related to Proinflammatory CytokinesVeronica Bordoni, Michele Bibas, Domenico Viola, et al.
The Journal of Infectious Diseases|August 29, 2002
Acute human immunodeficiency virus replication causes a rapid and persistent impairment of Vgamma9Vdelta2 T cells in chronically infected patients undergoing structured treatment interruptionFederico Martini, Fabrizio Poccia, Delia Goletti, et al.
Plos One|July 11, 2015
Vγ9Vδ2 T-Cell Polyfunctionality Is Differently Modulated in HAART-Treated HIV Patients according to CD4 T-Cell CountRita Casetti, Gabriele De Simone, Alessandra Sacchi, et al.
Plos One|August 28, 2014
Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjectsChiara Agrati, Concetta Castilletti, Eleonora Cimini, et al.
AIDS (London, England)|February 25, 2009
Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vgamma9Vdelta2 T cellsFabrizio Poccia, Cristiana Gioia, Federico Martini, et al.
Pageof 5